 |
市場調查報告書
商品編碼
2077529
病毒載體和質體DNA檢測服務市場：按服務類型、最終用戶和地區分類Viral Vector And Plasmid DNA Testing Services Market, By Service Type, By End User, and By Region |
||||||
價格
簡介目錄
病毒載體和質體DNA檢測服務市場預計在2026年達到4.667億美元，預計2033年將達到23.531億美元。預計從2026年到2033年，該市場將以26.0%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 4.667億美元 |
| 歷史數據時期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026年至2033年預測期間的複合年成長率： | 26.00% | 2033年市場規模預測： | 23.531億美元 |
病毒載體是基因治療領域最佳策略，而檢測服務對於及時開發基於病毒載體的藥物至關重要。病毒載體的特性在正交分析中發揮關鍵作用。從監管角度來看，這種表徵也至關重要，包括產品的安全性、鑑定、純度和有效性。目前，病毒載體正被開發用於治療癌症、神經病學、血液病學、眼科學、代謝性疾病和肌肉疾病等領域的多種疾病，並且是全球市場上多種病毒藥物的主要遞送系統。由於病毒藥物的眾多進展，製藥業對未來充滿信心。
市場動態
針對多種治療用途的病毒載體和質體DNA的持續臨床試驗預計將在預測期內推動市場成長。例如，2022年10月，臨床研究機構ICON plc宣布與沙烏地阿拉伯伊瑪目阿卜杜勒拉赫曼·本·費薩爾大學的研究人員合作，啟動一項I期臨床試驗，以評估一種用於預防COVID-19的pDNA候選疫苗在健康成年人中的安全性和免疫抗原性（兩劑或三劑接種方案）。此pDNA候選疫苗將以肌肉注射（IM）的方式接種於18至55歲的健康成年人。
同樣，2022年1月，生技公司GeneOne Life Science, Inc.與另一家生技公司Inovio Pharmaceuticals合作，宣布啟動臨床試驗，以評估GLS-5700的安全性、耐受性和免疫抗原性。 GLS-5700是一種針對茲卡病毒的合成DNA質體疫苗，目前正處於I期臨床試驗階段。
本研究的主要特點：
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數，介紹了全球病毒載體和質體DNA 檢測服務市場的主要公司概況：公司概況、產品系列、主要亮點、財務績效和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 全球病毒載體和質體DNA檢測服務市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過全球病毒載體和質體DNA 檢測服務市場分析中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- 一致性機會圖（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場吸引力分析
- 市場機遇
- 併購和合作
- 資金籌措及投資
- 病毒載體和血漿DNA檢測的未來前景
- 監管準則與合規性
- PEST分析
- 波特的分析
第4章 全球病毒載體與質體DNA檢測服務市場：依服務類型分類，2021-2033年
- 安全
- 遺傳性狀分析
- 純度
- 鑑別
- 功效
第5章 全球病毒載體與質體DNA檢測服務市場：依最終用戶分類，2021-2033年
- 製藥和生物技術產業
- 研究機構
第6章 全球病毒載體與質體DNA檢測服務市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第7章 競爭情勢
- Charles River Laboratories, Inc.
- WuXi AppTec Co., Ltd.
- Cobra Biologics and Pharmaceutical Services
- Merck KgaA
- Lonza
- Eurofins Scientific
- FinVector Vision Therapies
- Advanced Bioscience Laboratories, Inc.
- Takara Bio Inc.
- ViruSure GmbH
- Genezen Laboratories
- Akron BIoTech.
- Catalent, Inc
- AcuraBio.
- CATUG BIoTechnology.
- Creative Biogene.
- Aldevron
第8章
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI3637
Viral Vector And Plasmid Dna Testing Services Market is estimated to be valued at USD 466.7 Mn in 2026 and is expected to reach USD 2,353.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 26.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 466.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 26.00% | 2033 Value Projection: | USD 2,353.1 Mn |
Testing services are crucial for the timely development of viral vector-based medicines since viral vectors are the best strategy for gene therapies. Characterization of the viral vector plays an essential role for orthogonal analytical methods. Through the regulatory prospective which includes product safety, identification, purity, and potency, the characterization is significant. These days, viral vectors are the primary delivery system for a variety of virus-based medications that have been created for various therapies for conditions including cancer, neurology, hematology, ophthalmology, metabolic or muscular disorders and are accepted on the global market. The pharmaceutical industry has a bright future for several developments based on viral-based medicines.
Market Dynamics
The ongoing clinical trials on the viral vectors and plasmid DNA for various treatment is expected to fuel growth of the market in the forecast period. For instance, in October, 2022, ICON plc, a clinical research organization, in collaboration with researchers from Imam Abdulrahman Bin Faisal University, based in Saudi Arabia, announced the initiation of Phase-I clinical trial Study to Evaluate the Safety and Immunogenicity of 2 or 3 dose regimen of investigational Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults. The pDNA vaccine candidate is administered intramuscularly (IM) by immunizing healthy adults (18-55 years).
Similarly, in January 2022, GeneOne Life Science, Inc., a biotechnology company, in collaboration with Inovio Pharmaceuticals, a biotechnology company, announced initiation of clinical trial to assess the safety, tolerability, and immunogenicity of GLS-5700. GLS-5700 is a synthetic DNA plasmid vaccine against the Zika virus, which is currently in Phase -1.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global viral vector and plasmid DNA testing services market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study are Charles River Laboratories, Inc., WuXi AppTec Co., Ltd., Cobra Biologics and Pharmaceutical Services, Merck KgaA, Lonza, Eurofins Scientific, FinVector Vision Therapies, Advanced Bioscience Laboratories, Inc., Takara Bio Inc., ViruSure GmbH, Genezen Laboratories, Akron Biotech., Catalent, Inc, AcuraBio., CATUG Biotechnology., Creative Biogene and Aldevron
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global viral vector and plasmid DNA testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viral vector and plasmid DNA testing services market
Detailed Segmentation:
- Global Viral Vector and Plasmid DNA Testing Services Market, By Service Type (Revenue, USD Mn, 2021 - 2033)
- Safety
- Genetic Characterization
- Purity
- Identity
- Potency
- Global Viral Vector and Plasmid DNA Testing Services Market By End User:
- Pharmaceutical and Biotechnology Industries
- Research Organizations
- Global Viral Vector and Plasmid DNA Testing Services Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Charles River Laboratories, Inc.
- WuXi AppTec Co., Ltd.
- Cobra Biologics and Pharmaceutical Services
- Merck KgaA
- Lonza
- Eurofins Scientific
- FinVector Vision Therapies
- Advanced Bioscience Laboratories, Inc.
- Takara Bio Inc.
- ViruSure GmbH
- Genezen Laboratories
- Akron Biotech.
- Catalent, Inc
- AcuraBio
- CATUG Biotechnology.
- Creative Biogene.
- Aldevron
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Future Prospective of Viral vector and plasma DNA testing
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- PORTER's Analysis
4. Global Viral Vector and Plasmid DNA Testing Services Market, By Service Type, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Safety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Genetic Characterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Purity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Identity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Potency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
5. Global Viral Vector and Plasmid DNA Testing Services Market, By End User, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
- Pharmaceutical and Biotechnology Industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Viral Vector and Plasmid DNA Testing Services Market, By Region, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Charles River Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- WuXi AppTec Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cobra Biologics and Pharmaceutical Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- FinVector Vision Therapies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Advanced Bioscience Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ViruSure GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genezen Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Akron Biotech.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Catalent, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AcuraBio.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CATUG Biotechnology.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative Biogene.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aldevron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
DNA檢測套組市場：依檢測類型、技術、產品類型、檢體類型及最終用戶分類－2026-2032年全球市場預測親子鑑定家用試劑盒市場：2026-2032年全球市場預測（按檢測類型、技術、檢體類型、分銷管道、應用和最終用戶分類）
寵物DNA檢測市場規模、佔有率和成長分析：按產品類型、動物種類、檢體類型、技術、服務模式、分銷管道、應用和地區分類－2026-2033年產業預測
病毒載體生物分析檢測服務市場規模、佔有率和趨勢分析報告：按檢測、病毒載體、開發階段、最終用途、地區和細分市場預測（2026-2033 年）
DNA診斷：市場趨勢、競爭格局與市場預測（至2034年）DNA診斷市場：按技術、應用、產品類型和最終用戶分類－2026-2032年全球市場預測
寵物DNA檢測市場：依檢測類型、寵物種類、檢體類型、應用程式、服務類型、最終用戶和地區分類
寵物基因檢測和祖源分析服務市場預測至2034年－按產品類型、檢測類型、檢體類型、技術、最終用戶和地區分類的全球分析
全球DNA檢測套組市場規模、佔有率、趨勢和成長分析報告（2026-2034年）祖源與親緣關係檢測市場：2026-2032年全球市場預測（按檢測類型、銷售管道、應用和最終用戶分類）
▼